Iso-Sensitest Agar

Iso-Sensitest Agar is a medium developed specifically for anti-microbial susceptibility tests like the Disc Diffusion Method. This is a well-defined medium containing a stabilized mineral content to avoid antagonism to certain antimicrobials by metal ions. It allows the growth of the great majority of microorganisms without further supplementation. It can also be supplemented for fastidious organisms with 5% whole horse blood or 5% whole horse blood and 20mg/l beta-nicotinamide adenine dinucleotide (NAD). Some mutant strains which are totally dependent on thymine and thymidine for their growth will not grow on Iso-Sensitest Agar which has these two components at very low levels. Care must be taken to recognize these strains.\n\nCertain supplements interefere with anti-microbial activity and tests must be performed to measure their effect. These supplements and the anti-microbial agents affected (in parentheses) include: thymidine (trimethoprim), blood (sulfonamides, trimethoprim, aminoglycosides), carbon dioxide (aminoglycosides, erythromycin, lincomycin, tetracycline, novobiocin), cysteine and other sulfhydryl compounds (aminoglycosides), and Vitox/Isovitalex (sulfonamides, trimethoprim).\n\nThe addition of lysed horse erthrocytes to the medium is not required when carrying out anti-microbial susceptibility tests with trimethoprim and sulfonamides\n

Prices direct from United States Biological

Quick response times

Exclusive Biosave savings/discounts

SPECIFICATIONS

Catalog Number

I9090

Size

500g

References

1. Ericsson H. M. and Sherris J. C. (1971) Acta. Pathol. Microbiol. Scand. Suppl. 217. 1-90. 2. Garrod L. P. and Waterworth P. M. (1971) J. Clin. Path. 24. 779-789. 3. Reller L. B., Schoenknecht F. D., Kenny M. A. and Sherris J. C. (1974) J. Infect. Dis. 130. 454-463. 4. Duncan I. B. R. (1974) Antimicrob. Agents & Chemotherapy 5. 9-15. 5. Yourassowsky E., Vanderlinden M. P. and Schoutens E. (1974) J. Clin. Path. 27. 897-901. 6. Neussil H. (1976) Chemotherapy Vol.2. 33-40. 7. Bridson E. Y. (1976) Arztl. Lab. 22. 373-376. 8. Tanner E. I. and Bullin C. H. (1974) J. Clin. Path. 27. 565-568. 9. Thomas M. and Bond L. (1973) Med. Lab. Technol. 30. 277-279. 10. Barker J., Healing D. and Hutchinson J. G. P. (1972) J. Clin. Path. 25. 1086-1088. 11. Reynolds A. V., Hamilton-Miller J. M. T. and Brumfitt W. (1974) B.M.J. (ii) 778.\n12. Stewart Sheila M., Anderson Isobel M. E. and Malcolm Margaret G. G. (1975) J. Clin. Path. 28. 195-197.\n13. Bell S. M. (1975) Pathology 7. Suppl. 1-48. 14. Garrod L. P. and Waterworth P. M. (1969) J. Clin. Path. 22. 534-538. 15. Gilbert D. N., Kutscher E., Ireland P., Barnett J. A. and Sandford J. P. (1971) J. Infect. Dis. 124. (suppl.), S37-S45.\n16. Zimelis V. M. and Jackson G. G. (1973) J. Infect. Dis. 127. 663-669.\n17. Davis S. D., Ianetta A., Wedgewood R. J. (1971) J. Infect. Dis. 124. 610-612.\n18. Brenner V. C. and Sherris J. C. (1972) Antimicrob. Agents Chemother. 1. 116-122.\n19. Traub W. H. (1970) Appl. Microbiol. 20. 98-102.\n20. Acar J. F. (1980) Antibiotics in Laboratory Medicine, Lorian V. (Ed.) Williams and Wilkens, Baltimore, USA, 48-51.\n21. Hartzen S.H., Andersen L.P., Bremmelgaard A. et al (1997) Antimicrob. Ag. and Chemother. 41. 2634-2639.\n22. British Society for Antimicrobial Chemotherapy (2002) Disc Diffusion Method for Antimicrobial Susceptibility Testing. Version 2.1.1. BSAC.